 ROSELAND, N.J., March 10, 2021 GLOBE NEWSWIRE -- Milestone Scientific Inc. NYSE American:MLSS, a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has received Notice of Allowance from the European Patent Office EPO combining minimum intensity of nerve stimulation MIS and real-time injection pressure IP monitoring utilizing Milestones CompuFlo instrument and associated DPS Dynamic Pressure Sensing Technology to optimize needle tip location in ultrasound-guided peripheral nerve block PNB procedures. The technology was developed in conjunction with Dr. Olivier Choquet from the Lapeyronie University Hospital Montpellier France, a renowned expert in peripheral nerve block procedures, and Dr. Mark Hochman, D.D.S., Inventor and Clinical Director for Milestone Scientific. 